Literature DB >> 11051135

Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.

M Bohn1, K T Kraemer.   

Abstract

Ciclopirox is a synthetic hydroxypyridone antifungal agent. In contrast to the azoles, glucuronidation is the main metabolic pathway of ciclopirox; therefore interactions with drugs metabolized via the cytochrome P450 system are unlikely Ciclopirox is also distinct from the common systemic agents, which interfere with sterol biosynthesis. In fact, ciclopirox chelates trivalent cations (such as Fe3+), inhibits metal-dependent enzymes that are responsible for degradation of toxic metabolites in the fungal cells, and targets diverse metabolic (eg, respiratory) and energy producing processes in microbial cells. Ciclopirox is a broad spectrum antimicrobial with activity against all the usual dermatophytes as well as yeast and nondermatophyte molds. It has demonstrated activity against gram positive and negative bacteria, including resistant strains of Staphlococcus aureus. Ciclopirox exhibits fungal inhibitory activity (minimum inhibitory concentration < 4 microg/mL for dermatophytes) as well as fungicidal activity; to date resistance to the drug has not been identified. Ciclopirox has been formulated in a nail lacquer delivery system. After evaporation of volatile solvents in the lacquer, the concentration of ciclopirox in the remaining lacquer film reaches approximately 35%, providing a high concentration gradient for penetration into the nail. Radiolabel data demonstrate penetration into infected nails after only 1 application of the lacquer. Ciclopirox nail lacquer is a topical product that provides an active fungicidal agent in a delivery system capable of promoting nail penetration. With repeated applications, the antifungal agent is homogeneously distributed through all layers of the toenail achieving concentrations of ciclopirox in excess of inhibitory and fungicidal concentrations for most pathogens. Although ciclopirox readily penetrates nails, very low levels of ciclopirox are recoverable systemically, even after chronic use. Ciclopirox nail lacquer 8% is a topical product that provides an active fungicidal agent in a delivery system capable of penetrating nails.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11051135     DOI: 10.1067/mjd.2000.109072

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  17 in total

1.  Interaction between ciclopirox and acenocoumarol.

Authors:  José A Morales-Molina; Rosario Pérez-Moyano; Anna Fayet-Pérez; Olivia Urquízar-Rodríguez; M José Gíménez-López
Journal:  Eur J Clin Pharmacol       Date:  2012-07-12       Impact factor: 2.953

Review 2.  Pharmacokinetics of antifungal agents in onychomycoses.

Authors:  D Debruyne; A Coquerel
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Ciclopirox protects mitochondria from hydrogen peroxide toxicity.

Authors:  Sun J Lee; Youngnam Jin; Hye Young Yoon; Byung-Ok Choi; Hyoung Chun Kim; Yu-Kyoung Oh; Hee-Sun Kim; Won-Ki Kim
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

4.  The antitumor activity of the fungicide ciclopirox.

Authors:  Hongyu Zhou; Tao Shen; Yan Luo; Lei Liu; Wenxing Chen; Baoshan Xu; Xiuzhen Han; Jia Pang; Chantal A Rivera; Shile Huang
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

Review 5.  Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.

Authors:  Alessandro Subissi; Daniela Monti; Giuseppe Togni; Federico Mailland
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

6.  [Modern antimycotics. What the treating physician needs to know].

Authors:  C Seebacher
Journal:  Hautarzt       Date:  2004-02       Impact factor: 0.751

7.  Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome.

Authors:  Gry H Dihazi; Asima Bibi; Olaf Jahn; Jessica Nolte; Gerhard A Mueller; Wolfgang Engel; Hassan Dihazi
Journal:  World J Stem Cells       Date:  2013-01-26       Impact factor: 5.326

8.  Iontophoretically enhanced ciclopirox delivery into and across human nail plate.

Authors:  Jinsong Hao; Kelly A Smith; S Kevin Li
Journal:  J Pharm Sci       Date:  2009-10       Impact factor: 3.534

Review 9.  Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.

Authors:  Katarzyna Tabara; Anna E Szewczyk; Wojciech Bienias; Agnieszka Wojciechowska; Marta Pastuszka; Magdalena Oszukowska; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2015-02-03       Impact factor: 1.837

10.  Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway.

Authors:  Hongyu Zhou; Tao Shen; Chaowei Shang; Yan Luo; Lei Liu; Juming Yan; Yan Li; Shile Huang
Journal:  Oncotarget       Date:  2014-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.